T Cell Immunotherapy | List of Frontiers open access articles

Mini Review

Published on 22 May 2018

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors

in Cancer Immunity and Immunotherapy

Paris Kosti
John Maher
James N. Arnold

Frontiers in Immunology

doi 10.3389/fimmu.2018.01104

23,219 views
108 citations

Original Research

Published on 19 Aug 2021

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

in Viral Immunology

Kerstin M. Gergely
Jürgen Podlech
Sara Becker
Kirsten Freitag
Steffi Krauter
Nicole Büscher
Rafaela Holtappels
Bodo Plachter
Matthias J. Reddehase
Niels A. W. Lemmermann

Frontiers in Immunology

doi 10.3389/fimmu.2021.694588

5,902 views
8 citations

Review

Published on 07 Jul 2022

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions

in Cancer Immunity and Immunotherapy

Peng Zhang
Yang Zhang
Nan Ji

Frontiers in Immunology

doi 10.3389/fimmu.2022.927132

8,736 views
23 citations

Original Research

Published on 01 Jul 2024

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation

in Molecular Innate Immunity

Rachel S. Cooper
Catherine Sutherland
Linda M. Smith
Graeme Cowan
Mark Barnett
Donna Mitchell
Colin McLean
Stuart Imlach
Alan Hayes
Sharon Zahra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1412211

5,257 views
2 citations

Review

Published on 31 Mar 2023

A close look at current γδ T-cell immunotherapy

in Cancer Immunity and Immunotherapy

Ling Ma
Yanmin Feng
Zishan Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2023.1140623

20,972 views
48 citations

Review

Published on 25 Oct 2021

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges

in Neuro-Oncology and Neurosurgical Oncology

Dalia Haydar
Jorge Ibañez-Vega
Giedre Krenciute

Frontiers in Oncology

doi 10.3389/fonc.2021.718030

6,881 views
12 citations

Clinical Trial

Published on 02 Feb 2021

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma

in Molecular and Cellular Oncology

YuanBo Xue
Xun Lai
RuiLei Li
ChunLei Ge
BaoZhen Zeng
Zhen Li
QiaoFen Fu
LiuFang Zhao
SuWei Dong
JinYan Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.607362

8,403 views
11 citations

Review

Published on 19 Apr 2018

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer

in T Cell Biology

Timm Hoeres
Manfred Smetak
Dominik Pretscher
Martin Wilhelm

Frontiers in Immunology

doi 10.3389/fimmu.2018.00800

28,253 views
146 citations

Original Research

Published on 11 Jun 2024

PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy

in Vaccines and Molecular Therapeutics

Lingbin Wang
Haojie Jiang
Xuying Yin
Tingting Liang
Guoming Li
Chen Ding
Mina Yang
Lin Zhang
Junling Liu
Yanyan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415834

4,125 views

Original Research

Published on 18 Apr 2024

Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

in Cancer Immunity and Immunotherapy

Vikram Adhikarla
Dennis Awuah
Enrico Caserta
Megan Minnix
Maxim Kuznetsov
Amrita Krishnan
Jefferey Y. C. Wong
John E. Shively
Xiuli Wang
Flavia Pichiorri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1358478

5,672 views
17 citations

Review

Published on 26 Mar 2024

Targeting PRAME for acute myeloid leukemia therapy

in Cancer Immunity and Immunotherapy

Jinjun Yang
Mengran Chen
Jing Ye
Hongbing Ma

Frontiers in Immunology

doi 10.3389/fimmu.2024.1378277

7,470 views
11 citations

Review

Published on 12 Jul 2024

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

in Cancer Molecular Targets and Therapeutics

Yang Yu
Mengdie Yu
Lijie Luo
Zijing Zhang
Haiping Zeng
Yan Chen
Zeyu Lin
Mengnan Chen
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1405727

3,113 views
1 citation

Review

Published on 30 Oct 2025

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future

in Cancer Immunity and Immunotherapy

Fang Wang
Zhaoyuan Huang
Xiaoming Feng
Mingxia Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608277

2,915 views

Review

Published on 24 Jan 2025

The success of the tumor immunotherapy: neutrophils from bench to beside

in Cancer Immunity and Immunotherapy

Meng Zhu
Ru Jia
Xiaojie Zhang
Pingwei Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524038

4,599 views
7 citations

Original Research

Published on 28 Jul 2022

Efficient derivation of chimeric-antigen receptor-modified TSCM cells

in Viral Immunology

Emiko Kranz
Charles J. Kuhlmann
Joshua Chan
Patrick Y. Kim
Irvin S. Y. Chen
Masakazu Kamata

Frontiers in Immunology

doi 10.3389/fimmu.2022.877682

5,209 views
18 citations

Original Research

Published on 27 Apr 2022

T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma

in Cancer Immunity and Immunotherapy

Jiachen Wang
Kefeng Shen
Wei Mu
Weigang Li
Meilan Zhang
Wei Zhang
Zhe Li
Tong Ge
Zhoujie Zhu
Shangkun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.873789

8,561 views
8 citations

Articles

Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors

Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation

A close look at current γδ T-cell immunotherapy

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer

PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy

Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

Targeting PRAME for acute myeloid leukemia therapy

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies

Immunotherapy of chimeric antigen receptor NK cells: status and its promising future

The success of the tumor immunotherapy: neutrophils from bench to beside

Efficient derivation of chimeric-antigen receptor-modified TSCM cells

T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma